ERBB2 and breast cancer: Triple negative breast cancer (TNBC) is one of the BC subtypes defined by the lack of ER, PR, and HER2 expression, making this BC phenotype the most pathologically aggressive, with a higher risk of local and distant relapses and being more challenging to control [4,5,6].